Allergy Therapeutics Plc

(OTC) AGYTF

Current Price$0.11

Market Cap$696.58M

Since IPO (2004)-94%

5 Year+5,689%

1 Year+34%

1 Month+0%

Allergy Therapeutics Plc Financials at a Glance

Market Cap

$696.58M

Revenue (TTM)

$122.41M

Net Income (TTM)

$84.56M

EPS (TTM)

$-0.01

P/E Ratio

-8.46

Dividend

$0.00

Beta (Volatility)

0.37 (Low)

Dividend

$0.00

Beta (Volatility)

0.37 (Low)

Price

$0.11

Volume

20,000

Open

$0.11

Price

$0.11

Volume

20,000

Open

$0.11

Previous Close

$0.11

Daily Range

$0.11 - $0.11

52-Week Range

$0.09 - $0.11

Dividend

$0.00

Beta (Volatility)

0.37 (Low)

Price

$0.11

Volume

20,000

Open

$0.11

Previous Close

$0.11

Daily Range

$0.11 - $0.11

52-Week Range

$0.09 - $0.11

AGYTF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Allergy Therapeutics Plc

Industry

Pharmaceuticals

Sector

Health Care

Employees

612

CEO

Manuel Llobet, MBA

Website

www.allergytherapeutics.com

Headquarters

Worthing, BN14 8SA, GB

AGYTF Financials

Key Financial Metrics (TTM)

Gross Margin

41%

Operating Margin

-60%

Net Income Margin

-85%

Return on Equity

Return on Capital

-89%

Return on Assets

-69%

Earnings Yield

-11.82%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$696.58M

Shares Outstanding

6.33B

Volume

20.00K

Avg. Volume

1.38K

Financials (TTM)

Gross Profit

$34.50M

Operating Income

$28.16M

EBITDA

$40.40M

Operating Cash Flow

$39.42M

Capital Expenditure

$4.48M

Free Cash Flow

$43.90M

Cash & ST Invst.

$17.56M

Total Debt

$60.09M

Allergy Therapeutics Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$36.27M

+8.0%

Gross Profit

$19.32M

-5.9%

Gross Margin

53.26%

N/A

Market Cap

$696.58M

N/A

Market Cap/Employee

$1.14M

N/A

Employees

612

N/A

Net Income

$19.91M

-27.2%

EBITDA

$9.76M

-4.4%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$16.67M

-553.9%

Accounts Receivable

$10.98M

+10.5%

Inventory

$13.79M

+15.9%

Long Term Debt

$24.79M

+206.0%

Short Term Debt

$1.96M

+12.2%

Return on Assets

-68.96%

N/A

Return on Invested Capital

-88.54%

N/A

Free Cash Flow

$14.51M

-14.8%

Operating Cash Flow

$11.71M

-8.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

GLASFGlass House Brands Inc.

GLASFGlass House Brands Inc.$9.67+0.42%

BOIRFBoiron S.A.

BOIRFBoiron S.A.$30.00+0.00%

VRNOFVerano Holdings Corp.

VRNOFVerano Holdings Corp.$1.30+8.33%

CRLBFCresco Labs Inc.

CRLBFCresco Labs Inc.$1.09+0.00%

LBLTFLattice Biologics Ltd.

LBLTFLattice Biologics Ltd.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

RIVNRivian Automotive

RIVNRivian Automotive$15.02-0.08%

Questions About AGYTF

What is the current price of Allergy Therapeutics Plc?

Allergy Therapeutics Plc is trading at $0.11 per share.

What is the 52-week range for Allergy Therapeutics Plc?

Over the past 52 weeks, Allergy Therapeutics Plc has traded between $0.09 and $0.11.

How much debt does Allergy Therapeutics Plc have?

As of the most recent reporting period, Allergy Therapeutics Plc reported total debt of $82.34M.

How much cash does Allergy Therapeutics Plc have on hand?

Allergy Therapeutics Plc reported $17.53M in cash and cash equivalents in its most recent financial results.

What is Allergy Therapeutics Plc’s dividend yield?

Allergy Therapeutics Plc does not currently have a dividend yield.

Allergy Therapeutics Plc

Allergy Therapeutics Plc Financials at a Glance

AGYTF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Allergy Therapeutics Plc

AGYTF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Allergy Therapeutics Plc Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About AGYTF

What is the current price of Allergy Therapeutics Plc?

What is the 52-week range for Allergy Therapeutics Plc?

How much debt does Allergy Therapeutics Plc have?

How much cash does Allergy Therapeutics Plc have on hand?

What is Allergy Therapeutics Plc’s dividend yield?

Premium Investing Services